A/s Novo, 10% Owner at CoLucid Pharmaceuticals, Inc. (CLCD), bought 100,000 shares at $20.00 ($2.0M) on 2016-09-09, disclosed to the SEC on 2016-09-13.
Open-market purchase of $2.0M CLCD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| RETA | SELL | 2017-06-12 | $5.7M | — | Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $590K | — | Filing → |